Press release
Exogenous Bioactive Peptides Market Share Driven by Rising Functional Nutrition and Cosmetic Innovation | Valuates Reports
Exogenous Bioactive Peptides MarketThe global Exogenous Bioactive Peptides market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-30B16805/Global_Exogenous_Bioactive_Peptides_Market_Research_Report_2024
The Exogenous Bioactive Peptides Market is gaining strong momentum as industries increasingly adopt peptide-based formulations to enhance product performance, bioavailability, and targeted functionality. Expanding demand for functional nutrition, clean-label ingredients, and advanced skincare solutions continues to influence overall market size and shape evolving market trends. The shift toward science-backed ingredients, coupled with advancements in bioprocessing and extraction technologies, is accelerating market growth across multiple end-use sectors.
In the type segmentation, animal-derived peptides currently hold the largest market share, supported by their widespread use in nutraceuticals, skincare formulations, and functional food products due to their strong bioactivity and established clinical relevance. Meanwhile, vegetal peptides are emerging as the fastest-growing segment, benefiting from rising consumer preference for plant-based ingredients, sustainability-driven product development, and increasing innovation in plant protein hydrolysates. The presence of the other category adds further diversity, supporting development across niche applications.
By application, the food and beverages segment leads the market, driven by the growing adoption of peptides for muscle support, metabolic health, and functional enrichment in everyday nutrition. The cosmetics segment exhibits the strongest market growth, fueled by the rising popularity of peptide-based anti-aging formulations, skin-repair complexes, and bioactive beauty solutions. The others segment-covering pharmaceuticals, supplements, and research uses-also contributes meaningfully to the market's expansion.
Key players including American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, Seagarden AS, and Novo Nordisk A/S hold substantial market share through strong R&D capabilities, application-specific peptide innovation, and robust manufacturing technologies. Their focus on high-purity peptide production, diversified product portfolios, and scalable bioprocessing solutions continues to reinforce competitive positioning.
Regionally, North America dominates the market due to advanced biotechnology infrastructure, strong consumer adoption of functional foods, and active innovation in cosmeceuticals. Europe follows closely with strong regulatory support for bioactive ingredients and growing demand for scientifically validated wellness products. Asia-Pacific represents the fastest-growing region, powered by expanding nutraceutical markets, increasing skincare consumption, and rising manufacturing capacity. Latin America and Southeast Asia are also contributing to steady market growth as awareness of bioactive ingredients rises. Looking ahead, the global market forecast points toward continued expansion driven by breakthroughs in peptide engineering, clean-label formulation trends, and growing cross-industry applications.
by Type
• Animal
• Vegetal
by Application
• Food and Beverages
• Cosmetics
• Others
By Company
American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Merck KGaA, Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd., Anaspec Inc., Thermo Fisher Scientific, Seagarden AS, Novo Nordisk A/S
View full report
https://reports.valuates.com/market-reports/QYRE-Auto-30B16805/global-exogenous-bioactive-peptides
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exogenous Bioactive Peptides Market Share Driven by Rising Functional Nutrition and Cosmetic Innovation | Valuates Reports here
News-ID: 4309064 • Views: …
More Releases from Valuates Reports
Asynchronous Dual-Port DRAM Market Share Driven by High-Speed Data Access and Pa …
Asynchronous Dual-Port DRAM Market Size
The global market for Asynchronous Dual-Port DRAM was valued at US$ 374 million in the year 2024 and is projected to reach a revised size of US$ 537 million by 2031, growing at a CAGR of 5.3% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-14L20033/Global_Asynchronous_Dual_Port_DRAM_Market_Research_Report_2025
The Asynchronous Dual-Port DRAM Market is gaining steady market growth as industries increasingly rely on memory solutions that support simultaneous read and write operations…
β-Nicotinamide Mononucleotide (NMN) Market Share Driven by Expanding Health Sup …
β-Nicotinamide Mononucleotide (NMN) Market Size
The global market for β-Nicotinamide Mononucleotide (NMN) was valued at US$ 418 million in the year 2024 and is projected to reach a revised size of US$ 992 million by 2031, growing at a CAGR of 13.4% during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-16K9169/Global_%CE%B2_Nicotinamide_Mononucleotide_NMN_Market_Insights_and_Forecast_to_2028
The β-Nicotinamide Mononucleotide (NMN) Market is experiencing notable market growth as interest in cellular health, healthy aging, and metabolic support continues to rise across…
Aluminium Foil Market Share Driven by Packaging Demand, Energy Efficiency, and E …
Aluminium Foil - Market Size
The global market for Aluminium Foil was estimated to be worth US$ 21620 million in 2023 and is forecast to a readjusted size of US$ 29320 million by 2030 with a CAGR of 4.4% during the forecast period 2024-2030
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-4P1801/Global_Aluminium_Foil_Market_Insights_and_Forecast_to_2028
The Aluminium Foil Market continues to demonstrate resilient market growth, supported by its essential role across packaging, thermal management, and advanced electrical applications. Market trends reflect…
DNA Data Storage Market Share Driven by Exponential Data Generation and Advances …
DNA Data Storage Market
The global market for DNA Data Storage was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-29Y8377/Global_DNA_Data_Storage_Market_Insights_Forecast_to_2028
The DNA Data Storage Market is emerging as a transformative solution for long-term, high-density data preservation, driven by the rapid growth of digital information and limitations of…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…